百济神州(ONC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ONC 百济神州

盘前交易 05-12 09:24:41 EDT

310.75

-1.37

-0.44%

盘前310.75

+0.000.00%

08:43 EDT

最高318.00	最低309.15	成交量34.67万
今开317.20	昨收312.12	日振幅2.84%
总市值344.93亿	流通市值265.53亿	总股本1.11亿
成交额1.08亿	换手率0.41%	流通股本8,545万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ONC","market":"US","secType":"STK","nameCN":"百济神州","latestPrice":310.75,"timestamp":1778529600000,"preClose":312.12,"halted":0,"volume":346706,"hourTrading":{"tag":"盘前","latestPrice":310.75,"preClose":310.75,"latestTime":"08:43 EDT","volume":15790,"amount":4909926.7114,"timestamp":1778589820161,"change":0,"changeRate":0,"amplitude":0.022719},"delay":0,"changeRate":-0.004389337434320148,"floatShares":85449100,"shares":111000000,"eps":4.404108,"marketStatus":"盘前交易","change":-1.37,"latestTime":"05-12 09:24:41 EDT","open":317.2,"high":317.999,"low":309.15,"amount":108377417.9402,"amplitude":0.028351,"askPrice":317.99,"askSize":6,"bidPrice":309,"bidSize":7,"shortable":3,"etf":0,"ttmEps":4.404108,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778592600000},"marketStatusCode":1,"adr":0,"adrRate":13,"exchange":"NASDAQ","adjPreClose":310.75,"preHourTrading":{"tag":"盘前","latestPrice":310.75,"preClose":310.75,"latestTime":"08:43 EDT","volume":15790,"amount":4909926.7114,"timestamp":1778589820161,"change":0,"changeRate":0,"amplitude":0.022719},"postHourTrading":{"tag":"盘后","latestPrice":310.75,"preClose":310.75,"latestTime":"18:58 EDT","volume":3278,"amount":1018648.1,"timestamp":1778540286398,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.284860136174102,"impliedVol":0.499,"impliedVolPercentile":0.84},"requestUrl":"/m/hq/s/ONC","defaultTab":"news","newsList":[{"id":"2634228933","title":"百济神州一季度净利润超16亿元；今年医保谈判工作启动","url":"https://stock-news.laohu8.com/highlight/detail?id=2634228933","media":"21世纪经济报道","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634228933?lang=zh_cn&edition=full","pubTime":"2026-05-11 20:04","pubTimestamp":1778501046,"startTime":"0","endTime":"0","summary":"政策动向今年医保谈判工作启动近日，国家医保局发布《2026年国家基本医疗保险、生育保险和工伤保险药品目录及商业健康保险创新药品目录调整工作方案》，并向社会公开征求意见。21点评：根据《征求意见稿》，今年的工作程序仍分为准备、申报、评审、谈判、公布结果5个阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605113733316580.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605113733316580.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["ONC","688235","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634288993","title":"百济神州(06160)发布第一季度业绩 归母净利润16.08亿元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2634288993","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634288993?lang=zh_cn&edition=full","pubTime":"2026-05-11 18:57","pubTimestamp":1778497043,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)发布2026年第一季度业绩，该集团取得营业收入105.44亿元，同比增长31.0%;归属于上市公司股东的净利润16.08亿元，同比扭亏为盈;基本每股收益1.11元。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440306.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["06160","ONC","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633486147","title":"【券商聚焦】招银国际维持百济神州(ONC/06160)“买入”评级 指近期临床数据读出将验证创新管线价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2633486147","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633486147?lang=zh_cn&edition=full","pubTime":"2026-05-08 13:17","pubTimestamp":1778217451,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际研报指，百济神州 1Q26业绩强劲，盈利改善，管理层上调全年指引。此外，近期多项临床数据的读出将为公司估值的提升提供强有力的催化剂。此外，BTK CDAC的美国NDA预计将于下半年递交。实体瘤催化剂丰富： 在即将到来的ASCO年会上，公司将公布CDK4抑制剂、GPC3/4-1BB双抗及B7-H4 ADC的临床数据。CDK4抑制剂已经进入一线乳腺癌三期临床。GPC3/4-1BB双抗也已经进入后线肝癌注册临床阶段。维持“买入”评级，维持基于DCF模型的目标价392.43美元不变。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1980931","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688235","ONC","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633107844","title":"中金：维持百济神州(06160)跑赢行业评级 目标价250港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2633107844","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633107844?lang=zh_cn&edition=full","pubTime":"2026-05-08 09:37","pubTimestamp":1778204248,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中金发布研报称，综合考虑百济神州费用控制，维持2026年收入预测不变，上调盈利预测7.1%至6.5亿美元，并维持2027年盈利预测不变。该行维持跑赢行业评级，基于DCF模型，该行维持A/H/US股目标价320元/250港币/420美元。1Q26替雷利珠单抗全球销售额2.06亿美元，YoY +20%。GAAP净利润达到2.27亿美元，单季度盈利首次超过2亿美元，超过该行预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439361.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06160","688235","ONC","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633794147","title":"多家药企高管生变：恒瑞、复星、阿斯利康、辉瑞…","url":"https://stock-news.laohu8.com/highlight/detail?id=2633794147","media":"赛柏蓝","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633794147?lang=zh_cn&edition=full","pubTime":"2026-05-07 19:53","pubTimestamp":1778154780,"startTime":"0","endTime":"0","summary":"01本土制药企业与Biotech迎高管变动恒瑞医药、再鼎医药、百济神州、和铂医药、复星医药映射出了中国创新药发展过程中企业所处的不同阶段。4月16日，恒瑞医药发布公告，正式完成新一届董事会和管理层聘任。复星医药4月2日，复星医药发布首席财务官变更公告，因工作安排调整，陈战宇辞去首席财务官职务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-05-07/doc-inhxatff4708181.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4534","AZNH","IE00BLSP4239.USD","LU2237443549.SGD","LU0321505439.SGD","BK4550","BK4585","600276","LU0122379950.USD","06160","SG9999011175.SGD","IE00B19Z3B42.SGD","LU2462157665.USD","IE00B3T34201.USD","LU0234572021.USD","IE00B19Z3581.USD","LU0868494617.USD","BK4588","LU0456855351.SGD","LU0225771236.USD","LU0320765992.SGD","PFE","SG9999002224.SGD","BK4599","BK4568","IE0002270589.USD","LU1023059063.AUD","600196","LU1883839398.USD","LU1894683264.USD","LU0306807586.USD","LU1066051498.USD","AZN","01276","IE00BLSP4452.SGD","LU0058720904.USD","LU0170899867.USD","LU0289739699.SGD","LU2237443465.HKD","SG9999001176.SGD","02142","688235","LU0306806265.USD","LU0889565916.HKD","LU1894683348.USD","LU1829250122.USD","IE00BBT3K403.USD","SG9999001176.USD","02196","LU2237443382.USD","BK4007","ONC","LU2417539215.USD","SG9999013999.USD","LU0109394709.USD","LU2237443978.SGD","LU2237443622.USD","LU0985481810.HKD","LU1057294990.SGD","LU2456880835.USD","SG9999002232.USD","BK4581","BK4533","BK4592","LU2236285917.USD","LU1066053197.SGD","LU0321505868.SGD","SGXZ57979304.SGD","LU0225284248.USD","LU2237443895.HKD","SG9999003800.SGD","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633416218","title":"港股异动 | 百济神州(06160)绩后高开逾4% 一季度净利同比增长178.02倍 百悦泽全球销售额11亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2633416218","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633416218?lang=zh_cn&edition=full","pubTime":"2026-05-07 09:25","pubTimestamp":1778117150,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百济神州绩后高开逾4%，截至发稿，涨4.07%，报189.4港元，成交额4130.72万港元。消息面上，5月6日，百济神州公布2026年第一季度业绩，全球总收入达约15.13亿美元，同比增长35%。经调整经营利润约4.14亿美元，同比增长197%；经调整净利润约3.75亿美元，同比增长175%；净利润约2.27亿美元，同比增长178.02倍；自由现金流约1.61亿美元，同比增长14.03倍。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b1300d74fa2f8add3d36093521acc10f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438856.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1500","BK4526","LU1251922891.USD","LU1770034418.SGD","LU0307460666.USD","LU1719994722.HKD","BK4139","LU1303224171.USD","ONC","BK4585","LU1969619763.USD","BK4588","BK1583","LU0588546209.SGD","BK0239","BK1588","688235","LU2328871848.SGD","VXUS","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633162625","title":"港股开盘强势 恒指高开1.21% 快手-W(01024)涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633162625","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633162625?lang=zh_cn&edition=full","pubTime":"2026-05-07 09:24","pubTimestamp":1778117045,"startTime":"0","endTime":"0","summary":"金吾财讯 | 美伊将达成结束战争协议，刺激大市气氛向上，隔晚美股强势带动港股情绪，恒指高开1.21%，国企指数高开1.3%，恒生科技指数高开2.41%。期内，经调整净利润3.75亿美元，按年增加175%。东方证券高开1.87%，公司宣布，向卖方收购上海证券合计100%股权。该公司已向上海证交所申请A股5月7日复牌。内地股市假后复市，大市走势向好，沪综指高开高走，收市上升1.2%，沪深两市成交额超过三万亿元水平。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/YWY0NWM4YTUxZGFlZmZjNmE5MDYxNjI4NjU1Mjc3NzM1Mzg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YWY0NWM4YTUxZGFlZmZjNmE5MDYxNjI4NjU1Mjc3NzM1Mzg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"fbe774582fff1943fbc8392a6b2fba8b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1980764","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1497733557.USD","LU1023057109.AUD","LU1831875114.USD","LU1785774172.SGD","LU1719994722.HKD","600958","SGXZ62798434.SGD","LU0359201885.HKD","LU0708995583.HKD","LU0417516571.SGD","09888","LU0293314216.USD","LU0634319403.HKD","LU0862451837.USD","BIDU","LU1188198961.HKD","LU0320764599.SGD","XYIGY","SG9999001093.SGD","03993","00300","IE00B19Z5X02.USD","03958","09988","BK1608","603993","513600","LU1770034418.SGD","BK1590","LU0173614495.USD","LU2097828714.EUR","LU0211977185.USD","BK1575","LU2039709279.SGD","LU0348827113.USD","LU0405327148.USD","LU2097828805.USD","09961","LU1497734951.SGD","LU1961090484.USD","LU1522347837.USD","LU1497733631.SGD","TCOM","LU0540923850.HKD","BK1528","81024","LU0287142896.SGD","HHImain","LU1048588211.SGD","SG9999003461.SGD","LU0348783662.USD","LU0640798160.USD","SG9999006597.SGD","LU0572944931.SGD","LU2399975544.HKD","LU0348783233.USD","LU0463099449.HKD","LU0890818403.SGD","SGXZ86797644.SGD","HSTECH","01929","LU0593848301.USD","ONC","BK1521","BK1147","LU0051755006.USD","CJEWY","LU0469268626.HKD","BK1095","LU1813983027.USD","LU2097828557.USD","LU0675040207.SGD","688235","LU1251922891.USD","LU1634259557.SGD","01088","BK1226","LU0210526637.USD","CSUAY","LU0348767384.USD","LU0561508036.HKD","LU0456827905.SGD","LU0348766576.USD","LU0307460666.USD","LU0359201612.USD","BK1591","LU0359202008.SGD","LU1303224171.USD","601088","LU0348735423.USD","LU1720050803.USD","LU0140636845.USD","IE00BQJZWZ67.USD","LU0181495838.USD","LU0052750758.USD","LU0314109678.HKD","SG9999014674.SGD","LU0611395673.USD","LU0417516738.SGD","LU0072462343.USD","LU0348825331.USD","LU0348784397.USD","LU1115378108.SGD","LU0405327494.USD","BK1564","BK1615","BK1610","LU1224444064.USD","IE00BWDBJ730.SGD","LU0588546209.SGD","BK4585","LU1808992512.USD","LU1282651121.HKD","LU0417516902.SGD","00857","HSI","BK4588","601857","LU2293587155.HKD","LU0972618739.USD","LU0326950275.SGD","600938","00883","01024","06160","LU2328871848.SGD","LU1969619763.USD","LU2097828474.EUR","000333","LU0244354667.USD","02833","SG9999004220.SGD","LU0327786744.USD","LU1794554557.SGD","BABA","LU2097828631.EUR","00868","LU0441854154.USD","LU1328277881.USD","LU0862451753.SGD","01378","LU1634259391.SGD","MCHmain","LU0348805143.USD","LU1282651048.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633166139","title":"智通港股早知道 | 碳酸锂现货价格大幅上行 百济神州(06160)一季度净利润同比增长178.02倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2633166139","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633166139?lang=zh_cn&edition=full","pubTime":"2026-05-07 07:09","pubTimestamp":1778108970,"startTime":"0","endTime":"0","summary":"前十款智能手机合计贡献了全球 25% 的出货量，创下历年第一季度最高集中度。百济神州：一季度净利润同比增长178.02倍至2.27亿美元智通财经APP讯，百济神州公布2026年第一季度业绩，全球总收入达约15.13亿美元，同比增长35%。经调整经营利润约4.14亿美元，同比增长197%；经调整净利润约3.75亿美元，同比增长175%；净利润约2.27亿美元，同比增长178.02倍；自由现金流约1.61亿美元，同比增长14.03倍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"b1300d74fa2f8add3d36093521acc10f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438814.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","688235","06160","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159265378","title":"异动解读 | 一季度业绩扭亏为盈并上调全年预期，百济神州盘中大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=1159265378","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159265378?lang=zh_cn&edition=full","pubTime":"2026-05-06 23:17","pubTimestamp":1778080652,"startTime":"0","endTime":"0","summary":"百济神州今日盘中大涨5.19%，引起了市场的广泛关注。业绩增长主要得益于核心产品百悦泽全球销售额的强劲增长，该产品第一季度销售额达75.98亿元，同比增长33.5%，其中欧洲市场增速尤为亮眼，达51.4%。与此同时，公司基于核心产品在美国市场的领先地位及在欧洲等重要市场的持续扩张，上调了2026年全年业绩指引，预计全年营业收入区间上限从450亿元提升至452亿元。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b1300d74fa2f8add3d36093521acc10f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633139629","title":"核心产品放量！百济神州一季度营收达105亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2633139629","media":"21世纪经济报道","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633139629?lang=zh_cn&edition=full","pubTime":"2026-05-06 21:26","pubTimestamp":1778073960,"startTime":"0","endTime":"0","summary":"5月6日，百济神州（纳斯达克代码：ONC；香港联交所代码：06160；上交所代码：688235.SH）发布2026年第一季度业绩报告。报告期内，公司营业总收入为105.44亿元，同比增长31.0%。产品收入占总营收98%，达103.21亿元，同比增长29.3%，主要得益于百悦泽?（泽布替尼），以及安进公司授权产品和百泽安?（替雷利珠单抗）的销售增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605063728968110.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605063728968110.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06160","ONC","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633180313","title":"百济神州(688235.SH)：2026年第一季度归母净利润16.08亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2633180313","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633180313?lang=zh_cn&edition=full","pubTime":"2026-05-06 19:37","pubTimestamp":1778067472,"startTime":"0","endTime":"0","summary":"百济神州(688235.SH)发布公告，2026年第一季度公司产品收入为103.21亿元，较上年同比上升29.3%;2026年第一季度公司营业总收入为105.44亿元，较上年同比上升31.0%;2026年第一季度归属于母公司所有者的净利润为16.08亿元。报告期末，公司总资产为590.69亿元，较期初增加3.1%;归属于母公司的所有者权益为330.31亿元，较期初增加7.8%。","market":"us","thumbnail":"https://img.zhitongcaijing.com/astock/4.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/4.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"b1300d74fa2f8add3d36093521acc10f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438702.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["06160","688235","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117917036","title":"百济神州Q1净利润16.08亿元，同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=1117917036","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117917036?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:34","pubTimestamp":1778063668,"startTime":"0","endTime":"0","summary":"5月6日，$百济神州(ONC)$盘前涨近5%！该公司一季度营收为105.44亿元，同比增长31%；净利润为16.08亿元，上年同期亏损9450.3万元，同比扭亏为盈。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ca0e3dea87604e6a95a3bf5695c5bcab","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"百济神州Q1净利润16.08亿元，同比扭亏为盈","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK1161","06160","LU1969619763.USD","LU1770034418.SGD","LU1251922891.USD","LU0307460666.USD","LU2328871848.SGD","ONC","BK1500","BK4526","BK0239","LU1303224171.USD","BK1588","688235","BK1583","BK4139","LU1719994722.HKD","BK4588","LU0588546209.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632618011","title":"百济神州首次全年盈利背后：累计亏损超600亿元，大单品依赖与地缘政治隐忧｜财报异动透视镜","url":"https://stock-news.laohu8.com/highlight/detail?id=2632618011","media":"华夏时报网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632618011?lang=zh_cn&edition=full","pubTime":"2026-05-01 16:32","pubTimestamp":1777624341,"startTime":"0","endTime":"0","summary":"这家中国抗癌药明星企业交出了史上首份盈利年报，但高达612亿元的累计未弥补亏损、对单一产品的深度依赖，以及愈演愈烈的中美药品定价博弈，令其“全球肿瘤创新公司”的故事蒙上阴影。对百济神州而言，2025年本应是举杯相庆的一年。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605013727283548.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605013727283548.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["ONC","688235","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109645758","title":"财报前瞻｜百济神州本季度营收预计增19.61%，机构观点偏向谨慎乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=1109645758","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109645758?lang=zh_cn&edition=full","pubTime":"2026-04-29 09:07","pubTimestamp":1777424834,"startTime":"0","endTime":"0","summary":"百济神州将于2026年05月06日发布新一季度财报，市场关注度聚焦收入增速与利润改善的持续性，以及核心产品放量节奏与费用率控制的平衡。综合一致性预期，本季度百济神州营收预计为13.36亿美元，同比增长19.61%；调整后每股收益预计为0.87美元，同比增长221.34%；息税前利润预计为1.08亿美元，同比增长243.42%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜百济神州本季度营收预计增19.61%，机构观点偏向谨慎乐观","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630323200","title":"盈利不足两月，百济神州豪掷20亿美元押注三抗","url":"https://stock-news.laohu8.com/highlight/detail?id=2630323200","media":"21世纪经济报道","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630323200?lang=zh_cn&edition=full","pubTime":"2026-04-28 11:23","pubTimestamp":1777346580,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者季媛媛从“年年巨亏”到“首年盈利”，百济神州用了十五年。当这面象征盈利喜悦的旗帜刚刚升起，百济神州在此节点选择花费重金与一家biotech企业达成BD（授权交易）合作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604283721914325.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604283721914325.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","ONC","688235","LU1303224171.USD","BK1588","LU2328871848.SGD","LU0588546209.SGD","BK1583","BK1500","LU1770034418.SGD","LU1719994722.HKD","BK1161","LU1969619763.USD","BK4139","BK4526","BK0239","LU1251922891.USD","06160","BK4585","LU0307460666.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630393872","title":"百济神州(06160)与华辉安健签订《合作协议》引进三特异性创新药全球独家开发权益","url":"https://stock-news.laohu8.com/highlight/detail?id=2630393872","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630393872?lang=zh_cn&edition=full","pubTime":"2026-04-27 19:03","pubTimestamp":1777287828,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州 发布公告，2026 年 4 月 24 日，公司全资子公司百济神州广州与华辉安健签订了一份《合作协议》。此外，华辉安健同意在相关里程碑达成后，向百济神州广州支付其被百济神州广州授予相关知识产权许可的对价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434590.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK1500","LU1719994722.HKD","BK1574","BK4526","ONC","LU0588546209.SGD","06160","LU1969619763.USD","159992","LU1303224171.USD","BK4139","BK0239","06978","LU0307460666.USD","BK1588","LU2328871848.SGD","BK1583","BK4588","688235","LU1251922891.USD","LU1770034418.SGD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628093746","title":"百济神州：公司严格执行《企业会计准则》和各项具体会计准则、企业会计准则应用指南、企业会计准则解释及其他相关规定","url":"https://stock-news.laohu8.com/highlight/detail?id=2628093746","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628093746?lang=zh_cn&edition=full","pubTime":"2026-04-20 17:30","pubTimestamp":1776677400,"startTime":"0","endTime":"0","summary":"证券日报网讯4月20日，百济神州在互动平台回答投资者提问时表示，公司已在2026年4月15日披露的《百济神州2025年年度报告》中详细披露报告期内的公司营业收入、销售费用、管理费用的变动原因。公司严格执行《企业会计准则》和各项具体会计准则、企业会计准则应用指南、企业会计准则解释及其他相关规定，财务数据客观公允反映公司财务状况和生产经营成果，不存在跨期结转成本费用的情形。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604203710742828.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1500","BK1588","688235","BK1161","BK4526","BK4588","LU0307460666.USD","BK0239","BK4585","LU1251922891.USD","LU1303224171.USD","BK1583","LU1770034418.SGD","LU2328871848.SGD","LU1719994722.HKD","ONC","06160","LU1969619763.USD","LU0588546209.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627328932","title":"2025年A股药企薪酬：药明康德李革年薪3998万，百济神州人均薪酬94万","url":"https://stock-news.laohu8.com/highlight/detail?id=2627328932","media":"红星资本局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627328932?lang=zh_cn&edition=full","pubTime":"2026-04-15 19:00","pubTimestamp":1776250843,"startTime":"0","endTime":"0","summary":"红星资本局4月15日消息，随着年报季到来，A股已有超120家医药企业披露了2025年经营业绩，其员工薪酬也受到关注。红星资本局根据企业年报、数据统计发现，药明康德（603259.SH；2359.HK）创始人李革以3998万元的年薪暂列药企管理层第一，较第二名高出1800多万元，其连续位列A股管理层薪酬榜首。人均薪酬方面，百济神州达到94.63万元，位居第一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604153706121691.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02359","LU1688375341.USD","LU0039217434.USD","BK4139","LU1997245094.SGD","ONC","BK1583","LU0320764599.SGD","LU2039709279.SGD","LU0588546209.SGD","LU0307460666.USD","06160","LU0327786744.USD","LU1934453819.USD","LU0708995583.HKD","LU0348825331.USD","LU1979443071.USD","603259","LU1046422090.SGD","LU2328871848.SGD","LU0516422366.SGD","LU0572944931.SGD","SG9999002562.SGD","LU0051755006.USD","LU1720050803.USD","LU1808992512.USD","399300","LU1770034418.SGD","LU1719994722.HKD","LU2495084118.USD","159982","LU2488822045.USD","LU2242644610.SGD","BK1576","LU3063872942.SGD","688235","BK4588","LU0456842615.SGD","02269","BK1610","BK4526","LU0417516902.SGD","LU1242518857.USD","LU1997244956.HKD","LU2125910500.SGD","BK1589","IE00B0JY6N72.USD","LU1969619763.USD","LU0043850808.USD","LU0856984785.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627415479","title":"百济神州年营收382亿：净利14.6亿 安进与Baker是核心股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2627415479","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627415479?lang=zh_cn&edition=full","pubTime":"2026-04-15 09:52","pubTimestamp":1776217938,"startTime":"0","endTime":"0","summary":"百济神州有限公司（公司代码：688235 公司简称：百济神州）日前发布截至2025年12月31日的财报。财报显示，百济神州2025年营收为382.25亿，较上年同期的272亿增长40.46%；","market":"hk","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260415/6391184353468399959612189.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260415/6391184353468399959612189.jpeg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n33283/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["AMGN","688235","06160","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627445534","title":"百济神州(688235.SH)发布2025年度业绩，扭亏为盈至14.61亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2627445534","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627445534?lang=zh_cn&edition=full","pubTime":"2026-04-14 21:39","pubTimestamp":1776173982,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州 发布2025年年度报告，报告期内，公司实现营业收入382.25亿元，同比增长40.46%。实现归属于上市公司股东的净利润14.61亿元。2023年1月，根据两项3期试验结果，百悦泽获批用于治疗初治和复发性CLL或SLL成年患者。2024年3 月，百悦泽联合奥妥珠单抗获得FDA加速批准用于治疗R/RFL患者。2025年6月，FDA批准百悦泽的薄膜包衣片剂剂型用于所有已获批适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428519.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","LU0588546209.SGD","LU1770034418.SGD","BK0239","LU1303224171.USD","ONC","BK1500","LU1719994722.HKD","BK4139","BK1583","BK1588","LU2328871848.SGD","BK4526","LU1251922891.USD","BK4588","06160","BK4585","LU0307460666.USD","688235","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beonemedicines.com","stockEarnings":[{"period":"1week","weight":0.0458},{"period":"1month","weight":0.0035},{"period":"3month","weight":-0.1208},{"period":"6month","weight":-0.1768},{"period":"1year","weight":0.3395},{"period":"ytd","weight":0.0228}],"compareEarnings":[{"period":"1week","weight":0.0297},{"period":"1month","weight":0.0881},{"period":"3month","weight":0.0682},{"period":"6month","weight":0.0818},{"period":"1year","weight":0.31},{"period":"ytd","weight":0.0841}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BeOne Medicines AG（原名：BeiGene Ltd）是一家全球肿瘤学公司，致力于为全球癌症患者研发新疗法。该公司产品组合涵盖血液学和实体瘤，致力于开发多样化的新型疗法。其产品包Brukinsa、Tevimbra和Pamiparib。Brukinsa是一种口服的布鲁顿酪氨酸激酶(BTK)小分子抑制剂。Tevimbra是一种人源化免疫球蛋白G4（IgG4）抗程序性细胞死亡蛋白1（PD-1）单克隆抗体，具有高亲和力和对PD-1的结合特异性。Tevimbra旨在最大限度地减少与巨噬细胞上Fc-γ（Fcy）受体的结合，帮助人体免疫细胞检测和对抗肿瘤。该公司正在开发的产品线包括Sonrotoclax、Tarlatamab、Zanidatamab、Blinatumomab、BGB-26808、BGB-R046、BG-68501、BG-C9074、BGB-43395、Xaluritamig等。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.083709},{"month":2,"riseRate":0.6,"avgChangeRate":0.027535},{"month":3,"riseRate":0.363636,"avgChangeRate":-0.02929},{"month":4,"riseRate":0.363636,"avgChangeRate":0.018832},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.012592},{"month":6,"riseRate":0.5,"avgChangeRate":0.012468},{"month":7,"riseRate":0.8,"avgChangeRate":0.147208},{"month":8,"riseRate":0.6,"avgChangeRate":0.034201},{"month":9,"riseRate":0.6,"avgChangeRate":0.069537},{"month":10,"riseRate":0.5,"avgChangeRate":-0.004517},{"month":11,"riseRate":0.6,"avgChangeRate":0.063715},{"month":12,"riseRate":0.3,"avgChangeRate":-0.043663}],"exchange":"NASDAQ","name":"百济神州","nameEN":"BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百济神州(ONC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百济神州(ONC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百济神州,ONC,百济神州股票,百济神州股票老虎,百济神州股票老虎国际,百济神州行情,百济神州股票行情,百济神州股价,百济神州股市,百济神州股票价格,百济神州股票交易,百济神州股票购买,百济神州股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百济神州(ONC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百济神州(ONC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}